نتایج جستجو برای: hbv vaccine non

تعداد نتایج: 1426445  

2014
Pierre Sellier Nathalie Schnepf Rishma Amarsy Sarah Maylin Martin Coutellier Amanda Lopes Marie-Christine Mazeron Clara Flateau Marjolaine Morgand Nicole Ciraru-Vigneron Aurore Berthe Aude Ricbourg Anne-Marie Dolores-Moreno Guy Simoneau John Evans Safia Souak Sophie Matheron Stephane Mouly Jean-Louis Benifla François Simon Jean-François Bergmann

INTRODUCTION Human Immunodeficiency Virus (HIV) Mother-To-Child-Transmission (MTCT) and prevention by combined antiretroviral therapy (cART) have been extensively studied. Hepatitis B Virus (HBV) MTCT from HIV/HBV co-infected women and prevention by antiretroviral therapy with dual activity have been poorly studied. The aim of the study was to assess HBV MTCT from HIV/HBV co-infected women in a...

2017
Zhi-Xian Chen Xun Zhuang Xiao-Hong Zhu Yan-Li Hao Gui-Fang Gu Meng-Zhi Cai Gang Qin

Background Perinatal transmission is the main route of hepatitis B virus (HBV) transmission. While several measures have been attempted as means of preventing perinatal HBV transmission, the optimal strategy remains inconclusive. Methods We conducted a comprehensive search, through December 2016, for randomized controlled trials (RCTs) that compared the following measures among pregnant women...

Journal: :Memorias do Instituto Oswaldo Cruz 2003
Maria do Carmo M Elisbão José Luís da S Baldy Ana Maria Bonametti Edna Maria V Reiche Helena K Morimoto Rubens Pontello Tiemi Matsuo Antônio Ferelle Jayme Neves

Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 micrograms doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None ...

2003
Maria do Carmo M Elisbão José Luís da S Baldy Ana Maria Bonametti Edna Maria V Reiche Helena K Morimoto Rubens Pontello Tiemi Matsuo Antônio Ferelle Jayme Neves

Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 μg doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None of the d...

2016
Laura Scribano Veronica Vanin Giorgia Gottardo Diana Sacchi Francesco Paolo Russo

Patients with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are at significant risk for hepatocellular carcinoma (HCC). The most important risk factor associated with HCC is liver cirrhosis, which is again predominantly caused by chronic HBV or HCV infection. The most effective approach to avoid HCC development is to prevent HBV and HCV infection through vaccination. Ind...

Journal: :Vaccine 2008
Alain Luxembourg Drew Hannaman Ken Wills Robert Bernard Bud C Tennant Stephan Menne Paul J Cote

The licensed vaccine against hepatitis B virus (HBV) is an effective means to prevent infection, but is not an effective therapeutic strategy to treat established chronic infections when used alone. In an animal model of chronic HBV infection (the woodchuck experimentally infected with woodchuck hepatitis virus (WHV)), the combination of conventional vaccine and potent antiviral drugs has shown...

2006
Yong Poovorawan Thosporn Vimolket

To evaluate the cost-effectiveness of four infant vaccination strategies aimed at protecting the Thai population against hepatitis B virus (HBV) infection, vaccination and giving hepatitis B immunoglobulin (HBIg) to high-risk infants were compared with universal vaccination of infants and no vaccination. An analytic decision model was used to estimate the clinical and economic consequences of H...

Journal: :Journal of virological methods 2008
Yali Zhang Wenzheng Jiang Yan Fan Jiejun Wen Wenli Hao Min Qian

DNA vaccines could induce protective immune responses in several animal models. Many strategies have been employed to improve the effect of nucleic acid vaccines. LIGHT is a member of the TNF superfamily and functions as a co-stimulatory molecule for T cell proliferation. In the study, the immunogenicity in the induction of humoral and cellular immune responses by HBV DNA vaccine and the adjuva...

Journal: :Gaceta sanitaria 2014
Ana María Pedraza-Flechas Luis García-Comas María Ordobás-Gavín Juan Carlos Sanz-Moreno Belén Ramos-Blázquez Jenaro Astray-Mochales Santiago Moreno-Guillén

OBJECTIVE To estimate the prevalence of hepatitis B virus (HBV) infection and vaccine-induced immunity in the region of Madrid, and to analyze their evolution over time. METHODS An observational, analytical, cross-sectional study was carried out in the population aged 16-80 years between 2008 and 2009. This was the last of four seroprevalence surveys in the region of Madrid. The prevalence of...

Objective (s):The aim of this study was to determine the correlation between vaccine therapy and appearance of mutations in hepatitis B surface antigen (HBsAg)-positive chronic hepatitis B virus (HBV) patients. Materials and Methods: 16 patients received the HBV vaccine and another 16 individuals from the control group did not. The surface gene was amplified and directly sequenced from samples...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید